Integrated Whole Body MR/PET: Where Are We?

다국어 초록 (Multilingual Abstract)

Whole body integrated magnetic resonance imaging (MR)/positron emission tomography (PET) imaging systems have recently become available for clinical use and are currently being used to explore whether the combined anatomic and functional capabilities of MR imaging and the metabolic information of PET provide new insight into disease phenotypes and biology, and provide a better assessment of oncologic diseases at a lower radiation dose than a CT. This review provides an overview of the technical background of combined MR/PET systems, a discussion of the potential advantages and technical challenges of hybrid MR/PET instrumentation, as well as collection of possible solutions. Various early clinical applications of integrated MR/PET are also addressed. Finally, the workflow issues of integrated MR/PET, including maximizing diagnostic information while minimizing acquisition time are discussed.

참고문헌 (Reference)

1 Kinahan PE, "X-ray-based attenuation correction for positron emission tomography/computed tomography scanners" 33 : 166-179, 2003

2 von Schulthess GK, "Workflow Considerations in PET/MR Imaging" 55 (55): 19S-24S, 2014

3 Conti M., "Why is TOF PET reconstruction a more robust method in the presence of inconsistent data?" 56 : 155-168, 2011

4 von Schulthess GK, "Why buy a PET/MR for high end research?" 40 : 283-284, 2014

5 Antoch G, "Whole-body dual-modality PET/CT and whole-body MRI for tumor staging in oncology" 290 : 3199-3206, 2003

6 Lin C, "Whole-body diffusion-weighted magnetic resonance imaging with apparent diffusion coefficient mapping for staging patients with diffuse large B-cell lymphoma" 20 : 2027-2038, 2010

7 Donati OF, "Value of retrospective fusion of PET and MR images in detection of hepatic metastases : comparison with 18F-FDG PET/CT and Gd-EOB-DTPA-enhanced MRI" 51 : 692-699, 2010

8 Eiber M, "Value of a Dixon-based MR/PET attenuation correction sequence for the localization and evaluation of PET-positive lesions" 38 : 1691-1701, 2011

9 Heijmen L, "Tumour response prediction by diffusion-weighted MR imaging: ready for clinical use?" 83 : 194-207, 2012

10 Bailey DL, "Transmission scanning in emission tomography" 25 : 774-787, 1998

11 Catana C, "Toward implementing an MRI-based PET attenuation-correction method for neurologic studies on the MR-PET brain prototype" 51 : 1431-1438, 2010

12 Martinez-Möller A, "Tissue classification as a potential approach for attenuation correction in whole-body PET/MRI : evaluation with PET/CT data" 50 : 520-526, 2009

13 Defrise M, "Time-of-flight PET data determine the attenuation sinogram up to a constant" 57 : 885-899, 2012

14 Vaska P, "The state of instrumentation for combined positron emission tomography and magnetic resonance imaging" 43 : 11-18, 2013

15 Heiss WD, "The potential of PET/MR for brain imaging" 36 (36): S105-S112, 2009

16 Delso G, "The effect of limited MR field of view in MR/PET attenuation correctio" 37 : 2804-2812, 2010

17 Zaidi H, "The clinical role of fusion imaging using PET, CT, and MR imaging" 18 : 133-149, 2010

18 Nappi C, "State of the Art in Cardiac Hybrid Technology : PET/MR" 6 : 338-345, 2013

19 Kwee SA, "Solitary brain lesions enhancing at MR imaging : evaluation with fluorine 18 fluorocholine PET" 244 : 557-565, 2007

20 Nuyts J, "Simultaneous maximum a posteriori reconstruction of attenuation and activity distributions from emission sinograms" 18 : 393-403, 1999

21 Schwenzer NF, "Simultaneous PET/MR imaging in a human brain PET/MR system in 50 patients--current state of image quality" 81 : 3472-3478, 2012

22 Yong TW, "Sensitivity of PET/MR images in liver metastases from colorectal carcinoma" 14 : 264-268, 2011

23 Schmidt GP, "Screening for bone metastases : whole-body MRI using a 32-channel system versus dual-modality PET-CT" 17 : 939-949, 2007

24 Histed SN, "Review of functional/anatomical imaging in oncology" 33 : 349-361, 2012

25 Gaeta CM, "Recurrent and metastatic breast cancer PET, PET/CT, PET/MRI: FDG and new biomarkers" 57 : 352-366, 2013

26 Al-Nabhani KZ, "Qualitative and quantitative comparison of PET/CT and PET/MR imaging in clinical practice" 55 : 88-94, 2014

27 Chandarana H, "Pulmonary nodules in patients with primary malignancy : comparison of hybrid PET/MR and PET/CT imaging" 268 : 874-881, 2013

28 Disselhorst JA, "Principles of PET/MR Imaging" 55 (55): 2S-10S, 2014

29 Wehrl HF, "Preclinical and Translational PET/MR Imaging" 55 (55): 11S-18S, 2014

30 Purz S, "Potential Pediatric Applications of PET/MR" 55 (55): 32S-39S, 2014

31 Yoon SH, "Positron emission tomography/magnetic resonance imaging evaluation of lung cancer : current status and future prospects" 29 : 4-16, 2014

32 Eiber M, "Performance of whole-body integrated 18F-FDG PET/MR in comparison to PET/CT for evaluation of malignant bone lesions" 55 : 191-197, 2014

33 Punwani S, "Pediatric and adolescent lymphoma : comparison of whole-body STIR half-Fourier RARE MR imaging with an enhanced PET/CT reference for initial staging" 255 : 182-190, 2010

34 Herzog H, "PET/MRI: challenges, solutions and perspectives" 22 : 281-298, 2012

35 Platzek I, "PET/MRI in head and neck cancer : initial experience" 40 : 6-11, 2013

36 Schuler MK, "PET/MRI Imaging in High-Risk Sarcoma : First Findings and Solving Clinical Problems" 2013 : 793927-, 2013

37 Balyasnikova S, "PET/MR in oncology : an introduction with focus on MR and future perspectives for hybrid imaging" 2 : 458-474, 2012

38 Hirsch FW, "PET/MR in children. Initial clinical experience in paediatric oncology using an integrated PET/MR scanner" 43 : 860-875, 2013

39 Rauscher I, "PET/MR in Oncology: Non-18F-FDG Tracers for Routine Applications" 55 (55): 25S-31S, 2014

40 Rischpler C, "PET/MR imaging of atherosclerosis: initial experience and outlook" 3 : 393-396, 2013

41 Torigian DA, "PET/MR imaging : technical aspects and potential clinical applications" 267 : 26-44, 2013

42 Platzek I, "PET/MR for therapy response evaluation in malignant lymphoma : initial experience" 26 : 49-55, 2013

43 Weber WA, "PET/MR Imaging: A Critical Appraisal" 55 (55): 56S-58S, 2014

44 Gaertner FC, "PET/MR : a paradigm shift" 13 : 36-52, 2013

45 Collins CD, "PET/CT in oncology: for which tumours is it the reference standard?" 7 (7): S77-S87, 2007

46 Somer EJ, "PET-MR image fusion in soft tissue sarcoma: accuracy, reliability and practicality of interactive point-based and automated mutual information techniques" 30 : 54-62, 2003

47 Burger C, "PET attenuation coefficients from CT images : experimental evaluation of the transformation of CT into PET 511-keV attenuation coefficients" 29 : 922-927, 2002

48 Catana C, "PET and MR imaging: the odd couple or a match made in heaven?" 54 : 815-824, 2013

49 Buchbender C, "Oncologic PET/MRI, part 2: bone tumors, soft-tissue tumors, melanoma, and lymphoma" 53 : 1244-1252, 2012

50 Buchbender C, "Oncologic PET/MRI, part 1: tumors of the brain, head and neck, chest, abdomen, and pelvis" 53 : 928-938, 2012

51 Ohno Y, "Non-small cell lung cancer : whole-body MR examination for M-stage assessment--utility for whole-body diffusion-weighted imaging compared with integrated FDG PET/CT" 248 : 643-654, 2008

52 Thorek DL, "Non-invasive mapping of deep-tissue lymph nodes in live animals using a multimodal PET/MRI nanoparticle" 5 : 3097-, 2014

53 Kohan AA, "N staging of lung cancer patients with PET/MRI using a three-segment model attenuation correction algorithm : initial experience" 23 : 3161-3169, 2013

54 Neuner I, "Multimodal imaging utilising integrated MR-PET for human brain tumour assessment" 22 : 2568-2580, 2012

55 Pichler BJ, "Multimodal imaging approaches: PET/CT and PET/MRI" 185 (185): 109-132, 2008

56 Ollinger JM, "Model-based scatter correction for fully 3D PET" 41 : 153-176, 1996

57 Baur A, "Magnetic resonance imaging as a supplement for the clinical staging system of Durie and Salmon?" 95 : 1334-1345, 2002

58 Hofmann M, "MRI-based attenuation correction for whole-body PET/MRI : quantitative evaluation of segmentation-and atlas-based methods" 52 : 1392-1399, 2011

59 Berker Y, "MRI-based attenuation correction for hybrid PET/MRI systems : a 4-class tissue segmentation technique using a combined ultrashort-echo-time/Dixon MRI sequence" 53 : 796-804, 2012

60 Keereman V, "MRI-based attenuation correction for PET/MRI using ultrashort echo time sequences" 51 : 812-818, 2010

61 Hofmann M, "MRI-based attenuation correction for PET/MRI : a novel approach combining pattern recognition and atlas registration" 49 : 1875-1883, 2008

62 Park H, "Introducing parametric fusion PET/MRI of primary prostate cancer" 53 : 546-551, 2012

63 Quick HH, "Integrated whole-body PET/MR hybrid imaging : clinical experience" 48 : 280-289, 2013

64 Kubiessa K, "Initial clinical results of simultaneous 18F-FDG PET/MRI in comparison to 18F-FDG PET/CT in patients with head and neck cancer" 41 : 639-648, 2014

65 Jambor I, "Improved detection of localized prostate cancer using co-registered MRI and 11C-acetate PET/CT" 81 : 2966-2972, 2012

66 Aitken AP, "Improved UTE-based attenuation correction for cranial PET-MR using dynamic magnetic field monitoring" 41 : 012302-, 2014

67 Boss A, "Hybrid PET/MRI of intracranial masses : initial experiences and comparison to PET/CT" 51 : 1198-1205, 2010

68 Rischpler C, "Hybrid PET/MR imaging of the heart: potential, initial experiences, and future prospects" 54 : 402-415, 2013

69 Nensa F, "Hybrid PET/MR imaging of the heart : feasibility and initial results" 268 : 366-373, 2013

70 Wahl RL, "From RECIST to PERCIST: Evolving Considerations for PET response criteria in solid tumors" 50 (50): 122S-150S, 2009

71 Drzezga A, "First clinical experience with integrated whole-body PET/MR: comparison to PET/CT in patients with oncologic diagnoses" 53 : 845-855, 2012

72 Kim JS, "Feasibility of template-guided attenuation correction in cat brain PET imaging" 12 : 250-258, 2010

73 Ripa RS, "Feasibility of simultaneous PET/MR of the carotid artery : first clinical experience and comparison to PET/CT" 3 : 361-371, 2013

74 Boss A, "Feasibility of simultaneous PET/MR imaging in the head and upper neck area" 21 : 1439-1446, 2011

75 Platzek I, "FDG PET/MR for lymph node staging in head and neck cancer" 83 : 1163-1168, 2014

76 Delso G, "Evaluation of the attenuation properties of MR equipment for its use in a whole-body PET/MR scanner" 55 : 4361-4374, 2010

77 Gaertner FC, "Evaluation of feasibility and image quality of 68Ga-DOTATOC positron emission tomography/magnetic resonance in comparison with positron emission tomography/computed tomography in patients with neuroendocrine tumors" 48 : 263-272, 2013

78 MacDonald LR, "Effects of MR surface coils on PET quantification" 38 : 2948-2956, 2011

79 Townsend DW, "Dual-modality imaging : combining anatomy and function" 49 : 938-955, 2008

80 Czernin J, "Does PET/MR Imaging Improve Cancer Assessments? Literature Evidence from More Than 900 Patients" 55 (55): 59S-62S, 2014

81 Afaq A, "Diffusion-weighted magnetic resonance imaging for tumour response assessment: why, when and how?" 10 (10): S179-S188, 2010

82 Boss A, "Diffusion tensor imaging in a human PET/MR hybrid system" 45 : 270-274, 2010

83 Niekel MC, "Diagnostic imaging of colorectal liver metastases with CT, MR imaging, FDG PET, and/or FDG PET/CT: a meta-analysis of prospective studies including patients who have not previously undergone treatment" 257 : 674-684, 2010

84 Zaidi H, "Determination of the attenuation map in emission tomography" 44 : 291-315, 2003

85 Takenaka D, "Detection of bone metastases in non-small cell lung cancer patients: comparison of whole-body diffusion-weighted imaging (DWI), whole-body MR imaging without and with DWI, whole-body FDG-PET/CT, and bone scintigraphy" 30 : 298-308, 2009

86 Kuhn FP, "Contrast-enhanced PET/MR imaging versus contrast-enhanced PET/CT in head and neck cancer: how much MR information is needed?" 55 : 551-558, 2014

87 Jadvar H, "Competitive advantage of PET/MRI" 83 : 84-94, 2014

88 Kim JH, "Comparison of segmentation-based attenuation correction methods for PET/MRI: evaluation of bone and liver standardized uptake value with oncologic PET/CT data" 53 : 1878-1882, 2012

89 Souvatzoglou M, "Comparison of integrated whole-body [11C]choline PET/MR with PET/CT in patients with prostate cancer" 40 : 1486-1499, 2013

90 Afshar-Oromieh A, "Comparison of PET/CT and PET/MRI hybrid systems using a 68Ga-labelled PSMA ligand for the diagnosis of recurrent prostate cancer : initial experience" 41 : 887-897, 2014

91 Coenegrachts K, "Comparison of MRI(including SS SE-EPI and SPIO-enhanced MRI)and FDG-PET/CT for the detection of colorectal liver metastases" 19 : 370-379, 2009

92 Filss CP, "Comparison of 18F-FET PET and perfusion-weighted MR imaging : a PET/MR imaging hybrid study in patients with brain tumors" 55 : 540-545, 2014

93 Antoch G, "Combined PET/MRI: a new dimension in whole-body oncology imaging?" 36 (36): S113-S120, 2009

94 Bailey DL, "Combined PET/MR: Where are we now? Summary report of the second international workshop on PET/MR imaging April 8-12, 2013, Tubingen, Germany" 16 : 295-310, 2014

95 Wehrl HF, "Combined PET/MR imaging--technology and applications" 9 : 5-20, 2010

96 Andersen FL, "Combined PET/MR imaging in neurology : MR-based attenuation correction implies a strong spatial bias when ignoring bone" 84 : 206-216, 2014

97 von Schulthess GK, "Clinical positron emission tomography/magnetic resonance imaging applications" 43 : 3-10, 2013

98 Catalano OA, "Clinical impact of PET/MR imaging in patients with cancer undergoing same-day PET/CT: initial experience in 134 patients--a hypothesis-generating exploratory study" 269 : 857-869, 2013

99 Keereman V, "Challenges and current methods for attenuation correction in PET/MR" 26 : 81-98, 2013

100 Schulz V, "Automatic, three-segment, MR-based attenuation correction for whole-body PET/MR data" 38 : 138-152, 2011

101 Liu X, "Automated prostate cancer localization without the need for peripheral zone extraction using multiparametric MRI" 38 : 2986-2994, 2011

102 Montandon ML, "Atlas-guided non-uniform attenuation correction in cerebral 3D PET imaging" 25 : 278-286, 2005

103 Sun H, "Anatomical and functional volume concordance between FDG PET, and T2 and diffusion-weighted MRI for cervical cancer: a hybrid PET/MR study" 41 : 898-905, 2014

104 Leibfarth S, "A strategy for multimodal deformable image registration to integrate PET/MR into radiotherapy treatment planning" 52 : 1353-1359, 2013

105 von Schulthess GK, "A look ahead: PET/MR versus PET/CT" 36 (36): S3-S9, 2009

106 Dickson JC, "A comparison of CT-and MR-based attenuation correction in neurological PET" 41 : 1176-1189, 2014

107 Takei T, "A case of multimodality multiparametric 11C-choline PET/MR for biopsy targeting in prior biopsy-negative primary prostate cancer" 37 : 918-919, 2012